Stockholders' Equity - Schedule of Warrants (Detail) - Warrant - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Number | ||
| Beginning balance (in shares) | 5,653,981 | 8,744,698 |
| Granted (in shares) | 0 | 8,666,667 |
| Exercised (in shares) | 0 | (8,509,926) |
| Expired (in shares) | 0 | (3,247,458) |
| Ending balance (in shares) | 5,653,981 | 5,653,981 |
| Weighted Average Exercise Price | ||
| Beginning balance (in usd per share) | $ 1.40 | $ 1.40 |
| Granted (in usd per share) | 0 | 0.34 |
| Exercised (in usd per share) | 0 | 0.41 |
| Expired (in usd per share) | 0 | 1.08 |
| Ending balance (in usd per share) | $ 2.05 | $ 1.40 |
| Warrants exercisable (in shares) | 5,653,981 | 5,653,981 |
| Intrinsic value of warrants | $ 0 | $ 0 |
| Weighted Average Remaining Contractual Life (Years) | 2 years 7 months 13 days | 3 years 1 month 13 days |
| X | ||||||||||
- Definition Numbers No definition available.
|
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations in Period, Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|